Detalhe da pesquisa
1.
Cytidine deaminase status as a marker of response to azacytidine treatment in MDS and AML patients.
Br J Haematol
; 203(4): 625-636, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37691342
2.
A non-inferiority randomized phase III trial of standard immunotherapy by checkpoint inhibitors vs. reduced dose intensity in responding patients with metastatic cancer: the MOIO protocol study.
BMC Cancer
; 23(1): 393, 2023 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37131154
3.
Quantitative impact of pre-analytical process on plasma uracil when testing for dihydropyrimidine dehydrogenase deficiency.
Br J Clin Pharmacol
; 89(2): 762-772, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36104927
4.
Renal impairment and DPD testing: Watch out for false-positive results!
Br J Clin Pharmacol
; 88(11): 4928-4932, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35939355
5.
COVID-19 vaccine race: watch your step for cancer patients.
Br J Cancer
; 124(5): 860-861, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33288844
6.
Population modeling of tumor growth curves and the reduced Gompertz model improve prediction of the age of experimental tumors.
PLoS Comput Biol
; 16(2): e1007178, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32097421
7.
Deciphering the response and resistance to immune-checkpoint inhibitors in lung cancer with artificial intelligence-based analysis: when PIONeeR meets QUANTIC.
Br J Cancer
; 123(3): 337-338, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32541872
8.
Tumor uptake and associated greater efficacy of anti-Her2 immunoliposome does not rely on Her2 expression status: study of a docetaxel-trastuzumab immunoliposome on Her2+ breast cancer model (SKBR3).
Anticancer Drugs
; 31(5): 463-472, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31895102
9.
Pharmacodynamic Therapeutic Drug Monitoring for Cancer: Challenges, Advances, and Future Opportunities.
Ther Drug Monit
; 41(2): 142-159, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30883508
10.
Estimation of Unbound Carboplatin Clearance From Total Plasma Concentrations as a Means of Facilitating Therapeutic Drug Monitoring.
Ther Drug Monit
; 41(1): 66-74, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30299429
11.
Immune check points in cancer treatment: current challenges and perspectives.
Br J Cancer
; 129(9): 1365-1366, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37898723
12.
Population Pharmacokinetics of Gemcitabine and dFdU in Pancreatic Cancer Patients Using an Optimal Design, Sparse Sampling Approach.
Ther Drug Monit
; 39(3): 290-296, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28346313
13.
Metronomic reloaded: Theoretical models bringing chemotherapy into the era of precision medicine.
Semin Cancer Biol
; 35: 53-61, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26361213
14.
A phase Ia/Ib clinical trial of metronomic chemotherapy based on a mathematical model of oral vinorelbine in metastatic non-small cell lung cancer and malignant pleural mesothelioma: rationale and study protocol.
BMC Cancer
; 16: 278, 2016 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-27094927
15.
Beating the odds: efficacy and toxicity of dihydropyrimidine dehydrogenase-driven adaptive dosing of 5-FU in patients with digestive cancer.
Br J Clin Pharmacol
; 81(1): 124-30, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26392323
16.
Lethal toxicity after administration of azacytidine: implication of the cytidine deaminase-deficiency syndrome.
Pharmacogenet Genomics
; 25(6): 317-21, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25850965
17.
Recipient/donor contradictory genotypes with impact on drug pharmacogenetics after liver transplant: a deadly gift?
Pharmacogenet Genomics
; 24(10): 527-9, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25003625
18.
Can cytidine deaminase be used as predictive biomarker for gemcitabine toxicity and response?
Br J Clin Pharmacol
; 85(6): 1213-1214, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30866103
19.
Biodistribution, tumor uptake and efficacy of 5-FU-loaded liposomes: why size matters.
Pharm Res
; 31(10): 2677-84, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24752479
20.
Overcoming immuno-resistance by rescheduling anti-VEGF/cytotoxics/anti-PD-1 combination in lung cancer model.
Cancer Drug Resist
; 7: 10, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38510749